ArticlePloS one2013

A novel function of novobiocin: disrupting the interaction of HIF 1α and p300/CBP through direct binding to the HIF1α C-terminal activation domain.

Donglu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.